Tova Hershkovitz

575 total citations
16 papers, 167 citations indexed

About

Tova Hershkovitz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Clinical Biochemistry. According to data from OpenAlex, Tova Hershkovitz has authored 16 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Clinical Biochemistry. Recurrent topics in Tova Hershkovitz's work include Metabolism and Genetic Disorders (3 papers), RNA modifications and cancer (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Tova Hershkovitz is often cited by papers focused on Metabolism and Genetic Disorders (3 papers), RNA modifications and cancer (3 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Tova Hershkovitz collaborates with scholars based in Israel, United States and Denmark. Tova Hershkovitz's co-authors include Alina Kurolap, Adi Mory, Tamar Paperna, Hanna Mandel, Hagit Baris Feldman, Hagit Baris, Claudia Gonzaga‐Jauregui, Ann Saada, Nina Ekhilevitch and Liran I. Shlush and has published in prestigious journals such as The American Journal of Human Genetics, eLife and Journal of Medical Genetics.

In The Last Decade

Tova Hershkovitz

14 papers receiving 165 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tova Hershkovitz Israel 10 83 41 30 26 22 16 167
Birutė Burnytė Lithuania 7 103 1.2× 70 1.7× 10 0.3× 21 0.8× 14 0.6× 28 194
Riitta Sallinen Finland 9 97 1.2× 35 0.9× 59 2.0× 53 2.0× 14 0.6× 12 212
Martin A. Haagmans Netherlands 7 157 1.9× 43 1.0× 52 1.7× 19 0.7× 28 1.3× 11 301
Valeria Y. Vasileva Russia 11 187 2.3× 40 1.0× 29 1.0× 13 0.5× 28 1.3× 32 306
Yaser Heshmati Sweden 9 103 1.2× 36 0.9× 16 0.5× 30 1.2× 4 0.2× 15 201
Ok‐Hwa Kim South Korea 10 194 2.3× 124 3.0× 17 0.6× 15 0.6× 24 1.1× 12 318
Renata Posmyk Poland 11 129 1.6× 85 2.1× 17 0.6× 62 2.4× 8 0.4× 24 262
Atsuko Matsunaga Japan 9 117 1.4× 15 0.4× 23 0.8× 40 1.5× 8 0.4× 21 192
Borahm Kim South Korea 11 83 1.0× 84 2.0× 16 0.5× 24 0.9× 7 0.3× 21 289

Countries citing papers authored by Tova Hershkovitz

Since Specialization
Citations

This map shows the geographic impact of Tova Hershkovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tova Hershkovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tova Hershkovitz more than expected).

Fields of papers citing papers by Tova Hershkovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tova Hershkovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tova Hershkovitz. The network helps show where Tova Hershkovitz may publish in the future.

Co-authorship network of co-authors of Tova Hershkovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Tova Hershkovitz. A scholar is included among the top collaborators of Tova Hershkovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tova Hershkovitz. Tova Hershkovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Paperna, Tamar, et al.. (2024). Rapid exome sequencing for children with severe acute encephalopathy – A case series. European Journal of Medical Genetics. 68. 104918–104918. 1 indexed citations
2.
Hirsch, Yoel, Hanna Mandel, Tova Hershkovitz, et al.. (2022). Vici syndrome in Israel: Clinical and molecular insights. Frontiers in Genetics. 13. 991721–991721.
3.
Heinrich, Ronit, Tali Garin-Shkolnik, Tova Hershkovitz, et al.. (2021). Two de novo GluN2B mutations affect multiple NMDAR-functions and instigate severe pediatric encephalopathy. eLife. 10. 12 indexed citations
4.
Weiss, Karin, Tova Hershkovitz, Nina Ekhilevitch, et al.. (2021). Exome sequencing for neurodevelopmental disorders and the effect on patient management – a single center experience. Molecular Genetics and Metabolism. 132. S114–S115.
5.
Lachover‐Roth, Idit, Pazit Salamon, Tal Freund, et al.. (2020). Novel NCF2 Mutation Causing Chronic Granulomatous Disease. Journal of Clinical Immunology. 40(7). 977–986. 9 indexed citations
6.
Hershkovitz, Tova, Alina Kurolap, Galit Tal, et al.. (2020). A recurring NFS1 pathogenic variant causes a mitochondrial disorder with variable intra-familial patient outcomes. Molecular Genetics and Metabolism Reports. 26. 100699–100699. 10 indexed citations
7.
Hershkovitz, Tova, Alina Kurolap, Claudia Gonzaga‐Jauregui, et al.. (2019). A novel TUFM homozygous variant in a child with mitochondrial cardiomyopathy expands the phenotype of combined oxidative phosphorylation deficiency 4. Journal of Human Genetics. 64(6). 589–595. 21 indexed citations
8.
Weiss, Karin, Alina Kurolap, Tamar Paperna, et al.. (2018). Rare Disease Diagnostics: A Single-center Experience and Lessons Learnt. Rambam Maimonides Medical Journal. 9(3). e0018–e0018. 4 indexed citations
9.
Kurolap, Alina, Orly Eshach‐Adiv, Claudia Gonzaga‐Jauregui, et al.. (2018). Establishing the role of PLVAP in protein-losing enteropathy: a homozygous missense variant leads to an attenuated phenotype. Journal of Medical Genetics. 55(11). 779–784. 14 indexed citations
10.
Kurolap, Alina, Tova Hershkovitz, Adi Tabib, et al.. (2018). Eculizumab Is Safe and Effective as a Long‐term Treatment for Protein‐losing Enteropathy Due to CD55 Deficiency. Journal of Pediatric Gastroenterology and Nutrition. 68(3). 325–333. 20 indexed citations
11.
Hershkovitz, Tova, Alina Kurolap, Noa Ruhrman‐Shahar, et al.. (2018). Clinical diversity of MYH7‐related cardiomyopathies: Insights into genotype–phenotype correlations. American Journal of Medical Genetics Part A. 179(3). 365–372. 10 indexed citations
12.
Kurolap, Alina, Tova Hershkovitz, Adi Mory, et al.. (2016). Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine. The American Journal of Human Genetics. 99(5). 1172–1180. 25 indexed citations
13.
Ekhilevitch, Nina, Alina Kurolap, Danit Oz-Levi, et al.. (2015). Expanding the MYBPC1 phenotypic spectrum: a novel homozygous mutation causes arthrogryposis multiplex congenita. Clinical Genetics. 90(1). 84–89. 12 indexed citations
14.
Hershkovitz, Tova, et al.. (2014). Diagnosing heart failure in children with congenital heart disease and respiratory syncytial virus bronchiolitis. The American Journal of Emergency Medicine. 32(12). 1510–1512. 4 indexed citations
15.
Hershkovitz, Tova, et al.. (2012). Development of a Computerized Morphometry Application for Assessment of the Tumor Fraction in Colon Carcinoma Tissue Samples. Applied immunohistochemistry & molecular morphology. 21(1). 54–58. 3 indexed citations
16.
Hershkovitz, Tova, Gamal Hassoun, Liran I. Shlush, et al.. (2006). A homozygous missense mutation in PEPD encoding peptidase D causes prolidase deficiency associated with hyper-IgE syndrome. Clinical and Experimental Dermatology. 31(3). 435–440. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026